IBM Cognos Business Intelligence up to 10.0 cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.1 | $0-$5k | 0.00 |
Summary
A vulnerability was found in IBM Cognos Business Intelligence up to 10.0. It has been classified as problematic. This impacts an unknown function. The manipulation leads to cross site scripting. This vulnerability is uniquely identified as CVE-2012-4835. The attack is possible to be carried out remotely. No exploit exists. Upgrading the affected component is recommended.
Details
A vulnerability, which was classified as problematic, has been found in IBM Cognos Business Intelligence up to 10.0 (Business Process Management Software). This issue affects an unknown code block. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in IBM Cognos Business Intelligence (BI) 8.4.1 before IF1, 10.1 before IF2, 10.1.1 before IF2, and 10.2 before IF1 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
The weakness was disclosed 03/05/2013 (Website). The advisory is shared at xforce.iss.net. The identification of this vulnerability is CVE-2012-4835 since 09/06/2012. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
It is declared as highly functional.
Upgrading to version 10.1 eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at X-Force (78917). The entries VDB-63681, VDB-63680, VDB-63679 and VDB-63678 are pretty similar. If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Highly functional
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: Cognos Business Intelligence 10.1
Timeline
09/06/2012 🔍03/05/2013 🔍
03/05/2013 🔍
03/24/2015 🔍
02/06/2018 🔍
Sources
Vendor: ibm.comAdvisory: xforce.iss.net
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2012-4835 (🔍)
GCVE (CVE): GCVE-0-2012-4835
GCVE (VulDB): GCVE-100-63677
X-Force: 78917 - IBM Cognos Business Intelligence reflected cross-site scripting
See also: 🔍
Entry
Created: 03/24/2015 12:22Updated: 02/06/2018 08:44
Changes: 03/24/2015 12:22 (51), 02/06/2018 08:44 (3)
Complete: 🔍
Cache ID: 216:737:103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.